Resistance or pitfall in heparin monitoring: An ongoing issue in COVID‐19 anticoagulation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of laboratory hematology 2022-08, Vol.44 (4), p.e135-e137
Hauptverfasser:	Alsagaff, Mochamad Yusuf, Mulia, Eka Prasetya Budi
Format:	Artikel
Sprache:	eng
Schlagworte:	activated partial thromboplastin time anti‐Xa COVID-19 Heparin intensive care resistance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	e137
container_issue	4
container_start_page	e135
container_title	International journal of laboratory hematology
container_volume	44
creator	Alsagaff, Mochamad Yusuf Mulia, Eka Prasetya Budi
description
doi_str_mv	10.1111/ijlh.13778
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2610905771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2691225652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4218-3011e990f25762dadbbbe74f266bf51cd23fd15777734b8e9a9556a7c916b6be3</originalsourceid><addsrcrecordid>eNp9kM1Kw0AURgdRbK1ufAAJuBEhNXeSyWTclfrTSqEgKoKLMEkm7ZRkJmYSpDsfwWf0SZya6sKFd3O_xeFw74fQMXhDsHMhV8VyCD6l0Q7qAyXgEuI_7_5mDD10YMzK8wgNPLaPen7AIIAo6KOXe2GkabhKhaNrp5JNzovCkcpZiorXdpdayUbbtLh0RsrRaqFtdqQxrdhw4_nT9Orz_QOYw1UjU80XbcEbqdUh2rMyI462e4Aeb64fxhN3Nr-djkczNw0wRK7vAQjGvBwTGuKMZ0mSCBrkOAyTnECaYT_PgFA7fpBEgnFGSMhpyiBMwkT4A3TWeatav7bCNHEpTSqKgiuhWxPjEDxmf6dg0dM_6Eq3tbLXWYoBxiQk2FLnHZXW2pha5HFVy5LX6xi8eFN5vKk8_q7cwidbZZuUIvtFfzq2AHTAmyzE-h9VPL2bTTrpF1gHi5w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2691225652</pqid></control><display><type>article</type><title>Resistance or pitfall in heparin monitoring: An ongoing issue in COVID‐19 anticoagulation</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Alsagaff, Mochamad Yusuf ; Mulia, Eka Prasetya Budi</creator><creatorcontrib>Alsagaff, Mochamad Yusuf ; Mulia, Eka Prasetya Budi</creatorcontrib><identifier>ISSN: 1751-5521</identifier><identifier>EISSN: 1751-553X</identifier><identifier>DOI: 10.1111/ijlh.13778</identifier><identifier>PMID: 34914184</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>activated partial thromboplastin time ; anti‐Xa ; COVID-19 ; Heparin ; intensive care ; resistance</subject><ispartof>International journal of laboratory hematology, 2022-08, Vol.44 (4), p.e135-e137</ispartof><rights>2021 John Wiley & Sons Ltd.</rights><rights>Copyright © 2022 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4218-3011e990f25762dadbbbe74f266bf51cd23fd15777734b8e9a9556a7c916b6be3</citedby><cites>FETCH-LOGICAL-c4218-3011e990f25762dadbbbe74f266bf51cd23fd15777734b8e9a9556a7c916b6be3</cites><orcidid>0000-0002-2681-7743 ; 0000-0003-2194-6850</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijlh.13778$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijlh.13778$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34914184$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alsagaff, Mochamad Yusuf</creatorcontrib><creatorcontrib>Mulia, Eka Prasetya Budi</creatorcontrib><title>Resistance or pitfall in heparin monitoring: An ongoing issue in COVID‐19 anticoagulation</title><title>International journal of laboratory hematology</title><addtitle>Int J Lab Hematol</addtitle><subject>activated partial thromboplastin time</subject><subject>anti‐Xa</subject><subject>COVID-19</subject><subject>Heparin</subject><subject>intensive care</subject><subject>resistance</subject><issn>1751-5521</issn><issn>1751-553X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM1Kw0AURgdRbK1ufAAJuBEhNXeSyWTclfrTSqEgKoKLMEkm7ZRkJmYSpDsfwWf0SZya6sKFd3O_xeFw74fQMXhDsHMhV8VyCD6l0Q7qAyXgEuI_7_5mDD10YMzK8wgNPLaPen7AIIAo6KOXe2GkabhKhaNrp5JNzovCkcpZiorXdpdayUbbtLh0RsrRaqFtdqQxrdhw4_nT9Orz_QOYw1UjU80XbcEbqdUh2rMyI462e4Aeb64fxhN3Nr-djkczNw0wRK7vAQjGvBwTGuKMZ0mSCBrkOAyTnECaYT_PgFA7fpBEgnFGSMhpyiBMwkT4A3TWeatav7bCNHEpTSqKgiuhWxPjEDxmf6dg0dM_6Eq3tbLXWYoBxiQk2FLnHZXW2pha5HFVy5LX6xi8eFN5vKk8_q7cwidbZZuUIvtFfzq2AHTAmyzE-h9VPL2bTTrpF1gHi5w</recordid><startdate>202208</startdate><enddate>202208</enddate><creator>Alsagaff, Mochamad Yusuf</creator><creator>Mulia, Eka Prasetya Budi</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2681-7743</orcidid><orcidid>https://orcid.org/0000-0003-2194-6850</orcidid></search><sort><creationdate>202208</creationdate><title>Resistance or pitfall in heparin monitoring: An ongoing issue in COVID‐19 anticoagulation</title><author>Alsagaff, Mochamad Yusuf ; Mulia, Eka Prasetya Budi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4218-3011e990f25762dadbbbe74f266bf51cd23fd15777734b8e9a9556a7c916b6be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>activated partial thromboplastin time</topic><topic>anti‐Xa</topic><topic>COVID-19</topic><topic>Heparin</topic><topic>intensive care</topic><topic>resistance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alsagaff, Mochamad Yusuf</creatorcontrib><creatorcontrib>Mulia, Eka Prasetya Budi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of laboratory hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alsagaff, Mochamad Yusuf</au><au>Mulia, Eka Prasetya Budi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resistance or pitfall in heparin monitoring: An ongoing issue in COVID‐19 anticoagulation</atitle><jtitle>International journal of laboratory hematology</jtitle><addtitle>Int J Lab Hematol</addtitle><date>2022-08</date><risdate>2022</risdate><volume>44</volume><issue>4</issue><spage>e135</spage><epage>e137</epage><pages>e135-e137</pages><issn>1751-5521</issn><eissn>1751-553X</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34914184</pmid><doi>10.1111/ijlh.13778</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2681-7743</orcidid><orcidid>https://orcid.org/0000-0003-2194-6850</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1751-5521
ispartof	International journal of laboratory hematology, 2022-08, Vol.44 (4), p.e135-e137
issn	1751-5521 1751-553X
language	eng
recordid	cdi_proquest_miscellaneous_2610905771
source	Wiley Online Library Journals Frontfile Complete
subjects	activated partial thromboplastin time anti‐Xa COVID-19 Heparin intensive care resistance
title	Resistance or pitfall in heparin monitoring: An ongoing issue in COVID‐19 anticoagulation
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A13%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resistance%20or%20pitfall%20in%20heparin%20monitoring:%20An%20ongoing%20issue%20in%20COVID%E2%80%9019%20anticoagulation&rft.jtitle=International%20journal%20of%20laboratory%20hematology&rft.au=Alsagaff,%20Mochamad%20Yusuf&rft.date=2022-08&rft.volume=44&rft.issue=4&rft.spage=e135&rft.epage=e137&rft.pages=e135-e137&rft.issn=1751-5521&rft.eissn=1751-553X&rft_id=info:doi/10.1111/ijlh.13778&rft_dat=%3Cproquest_cross%3E2691225652%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2691225652&rft_id=info:pmid/34914184&rfr_iscdi=true